sincalide
Generic: sincalide
Labeler: fresenius kabi usa, llcDrug Facts
Product Profile
Brand Name
sincalide
Generic Name
sincalide
Labeler
fresenius kabi usa, llc
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
Active Ingredients
sincalide 5 ug/5mL
Manufacturer
Identifiers & Regulatory
Product NDC
63323-579
Product ID
63323-579_7aa01e72-178a-4161-b41b-f05bc8eba1a0
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA017697
Listing Expiration
2026-12-31
Marketing Start
2023-04-01
Pharmacologic Class
Established (EPC)
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
63323579
Hyphenated Format
63323-579
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
sincalide (source: ndc)
Generic Name
sincalide (source: ndc)
Application Number
NDA017697 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 5 ug/5mL
Packaging
- 10 VIAL in 1 PACKAGE (63323-579-05) / 5 mL in 1 VIAL (63323-579-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "7aa01e72-178a-4161-b41b-f05bc8eba1a0", "openfda": {"nui": ["M0004235", "N0000175798"], "upc": ["0363323579012"], "unii": ["M03GIQ7Z6P"], "rxcui": ["237982"], "spl_set_id": ["bb5057da-8568-49b9-947d-fab7d8d8f257"], "pharm_class_cs": ["Cholecystokinin [CS]"], "pharm_class_epc": ["Cholecystokinin Analog [EPC]"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL in 1 PACKAGE (63323-579-05) / 5 mL in 1 VIAL (63323-579-01)", "package_ndc": "63323-579-05", "marketing_start_date": "20230401"}], "brand_name": "SINCALIDE", "product_id": "63323-579_7aa01e72-178a-4161-b41b-f05bc8eba1a0", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Cholecystokinin Analog [EPC]", "Cholecystokinin [CS]"], "product_ndc": "63323-579", "generic_name": "sincalide", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "SINCALIDE", "active_ingredients": [{"name": "SINCALIDE", "strength": "5 ug/5mL"}], "application_number": "NDA017697", "marketing_category": "NDA", "marketing_start_date": "20230401", "listing_expiration_date": "20261231"}